Genetic and Pharmacological Modulation of Dendritic Cell-T Cell Interactions as a Therapeutic Strategy for Systemic Lupus Erythematosus

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|11|6|544-553

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.11, Iss.6, 2011-01, pp. : 544-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy

By Pego-Reigosa Jose Maria   Isenberg David A  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 1, 2008-01 ,pp. : 31-41

Informa Healthcare

Access to resources Recommend Favorite

B-Cell-Targeted Therapy for Systemic Lupus Erythematosus

By Sabahi Ramin   Anolik Jennifer H.  

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 1933-1948

Adis International

Access to resources Recommend Favorite

B cell depletion in systemic lupus erythematosus

By Leandro Maria J   Ehrenstein Michael R  

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 57-59

Royal College Of Physicians

Access to resources Recommend Favorite

The Dendritic Cell-T Cell Synapse as a Determinant of Autoimmune Pathogenesis

By  

Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. : 131-147

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Targets of Misguided T Cells in Systemic Lupus Erythematosus

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 295-298

Bentham Science Publishers

Access to resources Recommend Favorite